The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

All agenciesFDA (Food)FDA (Drugs)FDA (Devices)USDA FSISCPSCNHTSAEPA

Category

All categoriesFoodDrugMedical DeviceVehicleConsumer Product

Minimum severity

Any3+ (High and above)4+ (High and above)5+ (High and above)

Clear filters

5801–5825 of 18015

  • ModerateFDA (Drugs)·D-0106-2021·2020-11-25

    Apotex Recalls Aripiprazole Tablets Due to Dissolution Failures

    Apotex Corp. is recalling Aripiprazole Tablets 15 mg because they failed to meet dissolution specifications. The affected products were distributed nationwide in the USA.

    Product
    Aripiprazole Tablets, USP 15 mg tablets, packaged in a) 1000 count bottle, NDC 60505-2675-8; b) 30 count bottle, NDC 60505-2675-3; Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0090-2021·2020-11-25

    Milbar Recalls Malin+Goetz SPF 30 Face Moisturizer Due to GMP Deviations

    Milbar Laboratories is recalling 3,692 tubes of Malin+Goetz SPF 30 Face Moisturizer due to Good Manufacturing Practice (GMP) deviations.

    Product
    (Malin+Goetz) spf 30 face moisturizer (Avobenzone 3%, Homosalate 10 %, Octinoxate 7.5%, Octisalate 2.75%, Oxybenzone 5%) 1.7 fl. oz. 50 ml tubes, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0093-2021·2020-11-25

    Milbar Recalls Willa Pore Perfector Pads Due to GMP Deviations

    Milbar Laboratories is recalling 2,638 jars of Willa Pore Perfector pads due to Good Manufacturing Practice deviations. The product was distributed nationwide and internationally.

    Product
    Willa Pore Perfector (Salicylic Acid 2%) pads, 30 pads
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0092-2021·2020-11-25

    Milbar Recalls Willa Clear Skin Salicylic Acid Tubes Due to GMP Deviations

    Milbar Laboratories is voluntarily recalling 4,855 tubes of Willa Clear Skin (Salicylic Acid 2%) due to Good Manufacturing Practice (GMP) deviations. The product was distributed nationwide and internationally.

    Product
    Willa Clear Skin (Salicylic Acid 2%), 4.2 fl oz 124ml tubes, WBC Group LLC, Dist. Chandler, AZ 85226
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0085-2021·2020-11-25

    Milbar Recalls DCL AHA Lightening Gel Due to GMP Deviations

    Milbar Laboratories is recalling 1,608 bottles of DCL AHA Lightening Gel due to Good Manufacturing Practice deviations. The product was distributed nationwide and internationally.

    Product
    DCL AHA Lightening Gel (hydroquinone 2%), 30 ml/1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486500471
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0091-2021·2020-11-25

    Milbar Recalls MD Complete Breakout Treatment Due to GMP Deviations

    Milbar Laboratories is voluntarily recalling 2,655 bottles of MD Complete Breakout Treatment due to Good Manufacturing Practice deviations.

    Product
    MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) 1 fl. oz. (30mL) bottles, MD Professional LLC, Minneapolis, MN
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0087-2021·2020-11-25

    Milbar Recalls DCL T Shampoo for GMP Deviations

    Milbar Laboratories is voluntarily recalling 1,225 bottles of DCL T Shampoo due to Good Manufacturing Practice (GMP) deviations.

    Product
    DCL T Shampoo for Hair and Body ( Solution Coal Tar U.S.P. 3% and 0.6% Coal Tar), 300 ml/ 10.1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 3574865069947
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0084-2021·2020-11-25

    Milbar Recalls DCL B Prox10 Anti-Blemish Wash Due to GMP Deviations

    Milbar Laboratories is voluntarily recalling 7,591 bottles of DCL B Prox10 Anti-Blemish Wash due to Good Manufacturing Practice (GMP) deviations.

    Product
    DCL B Prox10 Anti-Blemish Wash (Benzoyl Peroxide 10%), 200 ml/6.7 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 0357486500853
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0099-2021·2020-11-25

    Grato Holdings Recalls Homeopathic Energy Catalyst for Undeclared API

    Grato Holdings is recalling 399 bottles of Homeopathic Energy Catalyst due to an undeclared active pharmaceutical ingredient and incorrect formulation.

    Product
    Homeopathic Energy Catalyst, 1 fl oz (30 mL) Distributed by: Deseret Biologicals, Inc. 469 W. Parkland Drive Sandy, UT 84070. NDC 43742-0756-1.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0088-2021·2020-11-25

    Milbar Recalls Malin + Goetz Dandruff Shampoo Due to GMP Deviations

    Milbar Laboratories is recalling 5,312 bottles of Malin + Goetz dandruff shampoo due to Good Manufacturing Practice deviations.

    Product
    (Malin + Goetz) dandruff Shampoo Psoriasis and Sebborrheic Dermatitis (1.9% Pyrithione Zinc) 8 fl.oz bottle, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0089-2021·2020-11-25

    Milbar Recalls Malin + Goetz Salicylic Gel Due to GMP Deviations

    Milbar Laboratories is recalling 2,664 tubes of Malin + Goetz Salicylic Gel due to Good Manufacturing Practice (GMP) deviations.

    Product
    (Malin + Goetz) Salicylic Gel (2% Salicylic Acid) 0.5 fl.oz. 15 mL tube, Distributed by: Malin+Goetz Inc 330 Seventh Avenue, New York, New York, 10001
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0086-2021·2020-11-25

    Milbar Recalls DCL SA Scalp Therapy Shampoo Due to GMP Deviations

    Milbar Laboratories is recalling 1,815 bottles of DCL SA Scalp Therapy Shampoo due to Good Manufacturing Practice (GMP) deviations.

    Product
    DCL SA Scalp Therapy Shampoo (Salicylic Acid 3%) 300 ml/10.1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486503120
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0072-2021·2020-11-18

    H & H Remedies Recalls White Liniment Due to CGMP Deviations

    H & H Remedies, LLC is voluntarily recalling 365 bottles of White Liniment due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    White Liniment packaged in a) 1 oz; b) 4 oz.; and c) 6 oz bottles. Mfg & Sold by: H & H Remedies, LLC c/o David A. Cox, 1219 South Broadway, New Philadelphia, OH 44663
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0076-2021·2020-11-18

    Baxter Recalls Bupivacaine Injection Due to Particulate Matter

    Baxter Healthcare is recalling specific lots of Bupivacaine Hydrochloride Injection due to the presence of black and transparent particles in the solution.

    Product
    Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India,
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0069-2021·2020-11-18

    Teva Recalls Mesalamine Tablets Due to Failed Dissolution Testing

    Teva Pharmaceuticals is recalling 133,829 bottles of Mesalamine Delayed-Release Tablets because stability testing revealed out-of-specification dissolution results.

    Product
    MESALAMINE — MESALAMINE (MESALAMINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0073-2021·2020-11-18

    H & H Remedies Recalls Vapor Ointment Due to Manufacturing Deviations

    H & H Remedies, LLC is voluntarily recalling 252 jars of Vapor Ointment due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    Vapor Ointment packaged in a) 1/8 oz; b) 2 oz.; c) 4 oz.; and d) 8 oz jars. Mfg & Sold by: H & H Remedies, LLC c/o David A. Cox, 1219 South Broadway, New Philadelphia, OH 44663
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0070-2021·2020-11-18

    AvKARE Recalls Mesalamine Tablets for Failed Dissolution Specifications

    AvKARE Inc. is recalling specific lots of Mesalamine Delayed-Release Tablets because they failed to meet dissolution specifications.

    Product
    Mesalamine Delayed-Release Tablets, USP 1.2 gram (Once-Daily), 120 Tablets bottle, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478 NDC 42291-564-12
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0071-2021·2020-11-18

    H & H Remedies Recalls Union Salve Due to CGMP Deviations

    H & H Remedies, LLC is voluntarily recalling 939 jars of Union (black) salve due to Current Good Manufacturing Practice (CGMP) deviations.

    Product
    Union (black) salve packaged in a) 1/8 oz; b) 2 oz.; c) 4 oz.; d) 8 oz.; e) 16 oz.; and f) 32 oz. jars. Mfg & Sold by: H & H Remedies, LLC c/o David A. Cox, 1219 South Broadway, New Philadelphia, OH 44663
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0067-2021·2020-11-11

    Nostrum Recalls Metformin Hydrochloride Extended-Release Tablets Due to NDMA Impurity

    Nostrum Laboratories is recalling Metformin Hydrochloride Extended-Release Tablets 750 mg because the NDMA impurity level exceeds acceptable intake limits.

    Product
    Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only. Manufactured by: Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-056-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0058-2021·2020-11-11

    Direct Rx Recalls Metformin Hydrochloride Extended Release Due to NDMA Impurity

    Direct Rx is recalling 88 bottles of Metformin Hydrochloride Extended Release 500 mg in Florida due to NDMA impurity levels above acceptable intake.

    Product
    METFORMIN HYDROCHLORIDE EXTENDED RELEASE — METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0060-2021·2020-11-11

    PD-Rx Recalls Metformin Hydrochloride Extended Release Tablets Due to NDMA

    PD-Rx Pharmaceuticals is recalling 125 bottles of Metformin Hydrochloride Extended Release tablets because of NDMA impurity levels above acceptable limits.

    Product
    METFORMIN HYDROCHLORIDE EXTENDED RELEASE — METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    16 states
  • SevereFDA (Drugs)·D-0059-2021·2020-11-11

    PD-Rx Recalls Metformin Hydrochloride Extended Release Due to NDMA Impurity

    PD-Rx Pharmaceuticals is recalling 1,683 bottles of Metformin Hydrochloride Extended Release 500 mg because of NDMA impurity levels above acceptable limits.

    Product
    METFORMIN HYDROCHLORIDE EXTENDED RELEASE — METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    16 states
  • SevereFDA (Drugs)·D-0056-2021·2020-11-11

    Denton Pharma Recalls Metformin Hydrochloride Tablets Due to NDMA Impurity

    Denton Pharma, Inc. is recalling Metformin Hydrochloride Extended-Release Tablets 750 mg due to the detection of N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels.

    Product
    Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0062-2021·2020-11-11

    Metformin Hydrochloride Extended Release Tablets Recalled for NDMA Impurity

    Marksans Pharma Limited is recalling Metformin Hydrochloride Extended Release tablets due to N-Nitrosodimethylamine (NDMA) impurity levels above acceptable intake limits.

    Product
    METFORMIN HYDROCHLORIDE EXTENDED RELEASE — METFORMIN HYDROCHLORIDE EXTENDED RELEASE (METFORMIN HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide